Regeneron Pharmaceuticals, Inc.
High Affinity Human Antibodies to Human Angiopoietin-2

Last updated:

Abstract:

The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.

Status:
Application
Type:

Utility

Filling date:

25 Nov 2020

Issue date:

8 Apr 2021